Treatment outcomes for patients with myelodysplastic syndrome/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis.

MLA

Komrokji, Rami, et al. “Treatment Outcomes for Patients with Myelodysplastic Syndrome/Myeloproliferative Neoplasms with Ring Sideroblasts and Thrombocytosis.” Leukemia & Lymphoma, vol. 63, no. 1, Jan. 2022, pp. 199–204. EBSCOhost, https://doi.org/10.1080/10428194.2021.1971217.

APA

Komrokji, R., Melody, M., Al Ali, N., Chan, O., Klimek, V., Ball, B. J., Sekeres, M. A., Lucas, G., Maciejewski, J. P., Sallman, D. A., Padron, E., Kuykendall, A., Lasho, T., Al-Kali, A., Naqvi, K., Steensma, D. P., Garcia-Manero, G., & Patnaik, M. M. (2022). Treatment outcomes for patients with myelodysplastic syndrome/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis. Leukemia & Lymphoma, 63(1), 199–204. https://doi.org/10.1080/10428194.2021.1971217

Chicago

Komrokji, Rami, Megan Melody, Najla Al Ali, Onyee Chan, Virginia Klimek, Brian J Ball, Mikkael A Sekeres, et al. 2022. “Treatment Outcomes for Patients with Myelodysplastic Syndrome/Myeloproliferative Neoplasms with Ring Sideroblasts and Thrombocytosis.” Leukemia & Lymphoma 63 (1): 199–204. doi:10.1080/10428194.2021.1971217.